AgomAb Therapeutics AGMB
NASDAQ AGMB
$8.73 +0.50 (+6.08%)
At close: Oct 20, 2026 · 4:00 PM EDT

AgomAb Therapeutics NV (AGMB) Non-Current Assets (2024 - 2026)

Updated

Agomab Therapeutics (AGMB) posted Non-Current Assets of $37.71 million for Q2 2026.

Analysis

AgomAb Therapeutics NV (AGMB) Non-Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Agomab Therapeutics' Non-Current Assets came in at $36.68 million, up 4.2% from FY2024.

  • In prior years, Agomab Therapeutics' Non-Current Assets was $35.19 million in FY2024.
  • The Q2 2026 figure stands as the lowest quarterly Non-Current Assets since Q4 2024.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 37.06 Mn
Dec 31, 2025 38.14 Mn
Dec 31, 2024 33.83 Mn
API Access

AgomAb Therapeutics NV Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=AGMB&period=max&api_key=YOUR_API_KEY